ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,802Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 973

$411K Total Retail Price of All Prescriptions

Rank: 225 out of 973

483 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 9,077 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 461 372 1 1
FUROSEMIDE 445 407 2 6
OMEPRAZOLE 381 312 3 5
LEVOTHYROXINE SODIUM 375 342 4 2
AMLODIPINE BESYLATE 347 347 5 7
LISINOPRIL 319 290 6 3
POTASSIUM CHLORIDE 268 230 7 9
HYDROCHLOROTHIAZIDE 267 251 8 11
CITALOPRAM HBR 240 197 9 14
MELOXICAM 227 188 10 23
METFORMIN HCL 219 195 11 8
METOPROLOL TARTRATE 218 195 12 13
HYDROCODONE-ACETAMINOPHEN 217 151 S3 13 4
ALENDRONATE SODIUM 215 204 14 24
WARFARIN SODIUM 200 171 15 10
POLYETHYLENE GLYCOL 3350 191 159 16 36
FENTANYL 176 118 S2 17 53
SERTRALINE HCL 146 131 18 21
ATENOLOL 146 138 18 16
TRAMADOL HCL 143 120 20 18
DIGOXIN 141 137 21 32
GABAPENTIN 116 110 22 12
ATORVASTATIN CALCIUM 114 104 23 15
GLYBURIDE 109 91 R 24 59
ZOLPIDEM TARTRATE 100 81 25 20
METOPROLOL SUCCINATE 95 86 26 17
CYCLOBENZAPRINE HCL 90 54 R 27 42
LOSARTAN POTASSIUM 90 86 27 19
CARVEDILOL 84 84 29 27
FLUTICASONE PROPIONATE 79 79 30 35
FAMOTIDINE 79 60 30 61
DONEPEZIL HCL 71 71 32 26
ISOSORBIDE MONONITRATE ER 70 56 33 85
SPIRONOLACTONE 64 62 34 49
SINGULAIR 64 56 34 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 63 36 25
ENALAPRIL MALEATE 63 51 36 55
CRESTOR 62 62 38 34
TAMSULOSIN HCL 60 50 39 28
OXYBUTYNIN CHLORIDE 59 59 40 92
AZITHROMYCIN 59 46 40 47
ALLOPURINOL 58 58 42 29
PREDNISONE 58 36 42 33
GLIPIZIDE ER 57 57 44 135
CLOPIDOGREL 57 54 44 44
PRAVASTATIN SODIUM 56 53 46 22
LOVASTATIN 54 31 47 38
OXYCODONE-ACETAMINOPHEN 54 51 S2 47 89
CIPROFLOXACIN HCL 54 49 47 57
QUETIAPINE FUMARATE 53 35 50 70
AMITRIPTYLINE HCL 53 47 R 50 52
ROPINIROLE HCL 52 36 52 72
GLIPIZIDE 51 51 53 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.